Views

CrossRef citations to date

Altmetric

Letters to the Editor: Clinical Oncology

The booster dose of BNT162b2 mRNA vaccine in patients after hematopoietic stem cell transplantation: humoral and clinical response and serological conversion predictors

Maciej Majchereka Department of Hematology and Bone Marrow Transplantation, Wroclaw Medical University, Wroclaw, PolandCorrespondence[email protected]

Agnieszka Matkowska-Kocjanb Department of Pediatric Infectious Diseases, Wroclaw Medical University, Wroclaw, Poland

Donata Szymczaka Department of Hematology and Bone Marrow Transplantation, Wroclaw Medical University, Wroclaw, Poland

Magdalena Karasekc University Hospital in Wroclaw, Wroclaw, Poland

Krzysztof Przeorskic University Hospital in Wroclaw, Wroclaw, Poland

Agnieszka Szeremeta Department of Hematology and Bone Marrow Transplantation, Wroclaw Medical University, Wroclaw, Poland

Aleksandra Kiragad Laboratory of Flow Cytometry and Cytomorphology, Department of Hematology and Bone Marrow Transplantation, University Hospital in Wroclaw, Wroclaw, Poland

Aneta Milanowskad Laboratory of Flow Cytometry and Cytomorphology, Department of Hematology and Bone Marrow Transplantation, University Hospital in Wroclaw, Wroclaw, Poland

Edwin Kuznike Department of Angiology, Hypertension and Diabetology, Wroclaw Medical University, Wroclaw, Poland

Krzysztof Kujawaf Statistical Analysis Centre, Wroclaw Medical University, Wroclaw, Poland

Tomasz Wrobela Department of Hematology and Bone Marrow Transplantation, Wroclaw Medical University, Wroclaw, Poland

Leszek Szenbornb Department of Pediatric Infectious Diseases, Wroclaw Medical University, Wroclaw, Poland

Anna Czyza Department of Hematology and Bone Marrow Transplantation, Wroclaw Medical University, Wroclaw, Poland

show all

Click to increase image sizeClick to decrease image size

Disclosure statement

No potential conflict of interest was reported by the author(s).

Data availability statement

The data that support the findings of this study are available from the corresponding author, [M.M], upon reasonable request.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

The booster dose of BNT162b2 mRNA vaccine in patients after hematopoietic stem cell transplantation: humoral and clinical response and serological conversion predictors

Information for

Open access

Opportunities

Help and information

The booster dose of BNT162b2 mRNA vaccine in patients after hematopoietic stem cell transplantation: humoral and clinical response and serological conversion predictors

Disclosure statement

Data availability statement

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature